Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Cash from Financing Activities (2020 - 2025)

Healthcare Triangle filings provide 6 years of Cash from Financing Activities readings, the most recent being $13.3 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 1555.29% to $13.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.9 million, a 19557.89% increase, with the full-year FY2025 number at $25.9 million, up 19557.89% from a year prior.
  • Cash from Financing Activities reached $13.3 million in Q4 2025 per HCTI's latest filing, up from $584000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $13.3 million in Q4 2025, with the low at -$883000.0 in Q1 2024.
  • A 5-year average of $2.7 million and a median of $623500.0 in 2024 define the central range for Cash from Financing Activities.
  • Year-over-year, Cash from Financing Activities skyrocketed 7971.43% in 2023 and then plummeted 1276.92% in 2024.
  • Year by year, Cash from Financing Activities stood at $11.4 million in 2021, then tumbled by 99.94% to $7000.0 in 2022, then skyrocketed by 7971.43% to $565000.0 in 2023, then soared by 42.12% to $803000.0 in 2024, then surged by 1555.29% to $13.3 million in 2025.
  • Per Business Quant, the three most recent readings for HCTI's Cash from Financing Activities are $13.3 million (Q4 2025), $584000.0 (Q3 2025), and -$360000.0 (Q2 2025).